1. Others
  2. Others

Others

Others Related Products (1025):

Cat. No. Product Name Effect Purity
  • HY-50202
    Etomoxir Inhibitor
    Etomoxir is a potent inhibitor of carnitine palmitoyltransferase-I (CPT-1).
  • HY-13005
    Fagomine Inhibitor
    Fagomine is a mild glycosidase inhibitor. The Ki of the iminosugar Fagomine is 4.8 μM, 39 μM, and 70 μM for Amyloglucosidase (A.niger), β-Glucosidase (bovine), and Isomaltase (yeast), respectively.
  • HY-10535
    TH-302
    TH-302 is a hypoxia-activated prodrug with IC50 of 10 μM and 1000 μM in hypoxia (N2) and Normoxia (21% O2), respectively.
  • HY-32264
    X-Neu5Ac
    X-Neu5Ac is a novel substrate for chromogenic assay of neuraminidase activity in bacterial expression systems.
  • HY-14658
    Thalidomide Inhibitor
    Thalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo.
  • HY-14127
    R121919 Antagonist
    R121919 is a potent small-molecule CRF1 receptor antagonist with a Ki of 2 to 5 nM for the CRF1 receptor and over 1000-fold weaker activity at the CRF2 receptor, CRF-binding protein, or 70 other receptor types.
  • HY-13336
    Imisopasem manganese
    Imisopasem manganese (M40403) is a stable non-peptidyl mimetic of manganese superoxide MnSOD.
  • HY-11101
    Alendronate sodium hydrate Inhibitor
    Alendronate (sodium hydrate) is a farnesyl diphosphate synthase inhibitor with IC50 of 460 nM.
  • HY-14281
    Trilostane Inhibitor
    Trilostane(Win 24540; Modrastane) is an inhibitor of 3 β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome.
  • HY-14452
    Fatostatin A Inhibitor
    Fatostatin A is a inhibitor of SREBP that directly binds SCAP and blocks its ER-to-Golgi transport with IC50 of 2.5 and 10 μM in mammalian cells.
  • HY-13056
    SMND-309 Activator
    SMND-309 is a novel derivative of salvianolic acid B, and has shown protective effects against rat cortical neuron damage in vitro and in vivo.
  • HY-76201
    Dexrazoxane Hydrochloride
    Dexrazoxane Hcl( ICRF-187 Hcl) is a cardioprotective agent.
  • HY-13215
    Avasimibe Inhibitor
    Avasimibe is a ACAT inhibitor incluing ACAT-1 and ACAT-2.
  • HY-15183
    Collagen proline hydroxylase inhibitor Inhibitor
    Collagen proline hydroxylase inhibitor is a collagen proline hydroxylase inhibitor; useful for antifibroproliferative agents.
  • HY-14347
    EBE-A22 Inhibitor
    EBE-A22 is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive.
  • HY-10704
    PTP1B-IN-1 Inhibitor
    PTP1B-IN-1 is a potent protein tyrosine phosphatase-1B (PTP1B) inhibitor with IC50 of 1.6 mM; 1,2,5-thiadiazolidin-3-one-1,1-dioxide scaffold for derivatives synthesis.
  • HY-13211
    (E)-2-Decenoic acid
    (E)-2-decanoic acid(trans-2-Decenoic Acid) is an interesting fatty acid isolated from royal jelly secretions of honey bees.
  • HY-13244
    NXY-059
    NXY-059 (Cerovive) is the disulfonyl derivative of the neuroprotective spin trap phenylbutynitrone(PBN), both NXY-059, its parent PBN and their hydrolysis/oxidation product MNT are very powerful scavengers of free radicals.
  • HY-B0025
    Voglibose Inhibitor
    Voglibose is an N-substituted derivative of valiolamine, excellent inhibitory activity against α-glucosidases and its action against hyperglycemia and various disorders caused by hyperglycemia.
  • HY-12119
    GW274150 Inhibitor
    GW274150 is a novel arginine-competitive, NADPH-dependent iNOS inhibitor that has been identified from a series of acetamide amino acids that have a high selectivity for iNOS vs both eNOS (> 260-fold) and nNOS (> 219-fold) and high bioavailability (> 90%) after oral administration.